(Q46518415)

English

Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

scientific article published on 25 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

R Krishna

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

A J Bergman

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

B Jin

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

M Fallon

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

J Cote

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

P Van Hoydonck

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

T Laethem

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

I N Gendrano

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

K Van Dyck

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

D Hilliard

10

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

O Laterza

11

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

K Snyder

12

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

C Chavez-Eng

13

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

R Lutz

14

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

J Chen

15

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

D M Bloomfield

16

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

M De Smet

17

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

L M Van Bortel

18

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

M Gutierrez

19

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

N Al-Huniti

20

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

K Dykstra

21

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

K M Gottesdiener

22

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

J A Wagner

23

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

language of work or name

0 references

publication date

25 June 2008

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

84

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

679-683

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Pfizer stops clinical trials of heart drug

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Model-based development of gemcabene, a new lipid-altering agent

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Development of a self-emulsifying formulation that reduces the food effect for torcetrapib

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.109

21 January 2018

Identifiers

10.1038/CLPT.2008.109

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18580870

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46518415&oldid=2143965244"